A significant advance in cancer study is emerging with the use of VHH fragments to restore dysfunctional p53. This vital tumor inhibitor protein is frequently disabled in several types of malignancies, resulting https://pr6bookmark.com/story22156641/vhh-fragments-reactivate-tumor-suppressor-p53-a-potential-pathway-for-cancer-management